INVO Fertility (IVF) Amortization of Deferred Charges (2012 - 2023)
INVO Fertility's (IVF) quarterly Amortization of Deferred Charges came in at $57859.0 in Q1 2023, up 1.69% year-on-year from $56899.0 in Q1 2022, and little changed on a QoQ basis from $57614.0 in Q4 2022.
INVO Fertility (IVF) Amortization of Deferred Charges (2012 - 2023) Analysis & Trends
INVO Fertility (IVF) has 5 years of Amortization of Deferred Charges data on file, last reported at $57859.0 in Q1 2023.
- On a quarterly basis, Amortization of Deferred Charges rose 1.69% year-over-year to $57859.0 in Q1 2023; TTM through Mar 2023 was $247647.0, a 1.67% increase from a year earlier, with the FY2022 full-year figure at $229018.0, up 65.57% from the prior year.
- Amortization of Deferred Charges for Q1 2023 stood at $57859.0, roughly flat from $57614.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for IVF reached as high as $75275.0 in Q4 2021 and fell as low as $50220.0 in Q4 2020.
- Historically, Amortization of Deferred Charges has averaged $59842.3 across 4 years, with a median of $57736.5 in 2022.
- Across the five-year window, Amortization of Deferred Charges jumped 49.89% in 2021 and decreased 23.46% in 2022, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $50220.0 in 2020, then surged by 49.89% to $75275.0 in 2021, then decreased by 23.46% to $57614.0 in 2022, then rose by 0.43% to $57859.0 in 2023.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $57859.0 in Q1 2023, $57614.0 in Q4 2022, and $56899.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | INVO Fertility | 1.54 Mn | -3.36 Mn | 732,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 57,859.00 |
| Mar 31, 2023 | 57,859.00 |
| Dec 31, 2022 | 57,614.00 |
| Dec 31, 2022 | 57,614.00 |
| Mar 31, 2022 | 56,899.00 |
| Mar 31, 2022 | 56,899.00 |
| Dec 31, 2021 | 75,275.00 |
| Dec 31, 2021 | 75,275.00 |
| Dec 31, 2020 | 50,220.00 |
| Dec 31, 2020 | 50,220.00 |
| Sep 30, 2020 | 61,187.00 |
| Sep 30, 2020 | 61,187.00 |
| Sep 30, 2012 | 17,992.00 |
| Sep 30, 2012 | 17,992.00 |